{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:29:25Z","timestamp":1793730565288,"version":"4.6.1"},"reference-count":98,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with CKD. Although the association between CKD and CVD is well established, the overall CVD burden, dominant cardiovascular phenotypes, and clinical outcomes vary substantially across populations. These differences are often described using racial or ethnic categories, yet emerging evidence suggests that they more closely reflect variation in cardiometabolic risk, inflammatory burden, environmental exposures, and health care access than race itself. This review synthesizes evidence from major CKD cohorts, including Chronic Renal Insufficiency Cohort (United States), German CKD, Chronic Renal Insufficiency Standards Implementation Study, and European Quality Study (Europe) and CKD Japan Cohort (Japan), Chinese Cohort Study of CKD (China), and KoreaN Cohort Study for Outcomes in Patients With CKD (Korea), to examine global patterns of cardiovascular burden and outcomes in CKD. North American and European CKD cohorts are characterized by greater inflammatory burden, more severe coronary artery calcification, and more pronounced left ventricular hypertrophy, corresponding to a clinical trajectory more heavily dominated by cardiovascular events and mortality. By contrast, East Asian cohorts show fewer overt atherosclerotic and cardiac structural abnormalities and a more kidney-dominant trajectory, in which kidney outcomes are more prominent relative to cardiovascular events. Genetic, environmental, and lifestyle-related modifiers likely contribute to these divergent cardiorenal phenotypes. Collectively, current evidence supports moving beyond race-based descriptions toward phenotype-informed and exposure-informed approaches to cardiovascular risk assessment in CKD, in which integration of imaging markers, inflammatory biomarkers, and cardiometabolic profiles may improve the precision and equity of cardiovascular prevention strategies across diverse CKD populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.0000001156","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:00:28Z","timestamp":1782144028000},"page":"1800-1813","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular Disease in CKD"],"prefix":"10.2215","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7726-2143","authenticated-orcid":false,"given":"Jwa-Kyung","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang-si, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Joon","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2263-3274","authenticated-orcid":false,"given":"Jung-Sun","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7867-1240","authenticated-orcid":false,"given":"Hyeon Chang","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4636-5745","authenticated-orcid":false,"given":"Cheol Ho","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4510-2823","authenticated-orcid":false,"given":"Hee Byung","family":"Koh","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6305-452X","authenticated-orcid":false,"given":"Hyung Woo","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7923-5635","authenticated-orcid":false,"given":"Seung Hyeok","family":"Han","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Institute of Kidney Disease Research, Yonsei University College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"10518","key":"B1-20261103","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the global burden of disease study 2023","volume":"406","year":"2025","journal-title":"Lancet."},{"issue":"4S","key":"B2-20261103","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int."},{"issue":"10523","key":"B3-20261103","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0140-6736(25)01942-7","article-title":"Chronic kidney disease","volume":"407","author":"Herrington","year":"2026","journal-title":"Lancet."},{"issue":"13","key":"B4-20261103","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis","volume":"330","author":"Grams","year":"2023","journal-title":"JAMA."},{"issue":"11","key":"B5-20261103","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation."},{"issue":"10","key":"B6-20261103","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/ndt\/gfae048","article-title":"Global health inequalities of chronic kidney disease: a meta-analysis","volume":"39","author":"Duff","year":"2024","journal-title":"Nephrol Dial Transplant."},{"issue":"6","key":"B7-20261103","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/heart.89.6.681","article-title":"Ethnic differences in cardiovascular disease","volume":"89","author":"Chaturvedi","year":"2003","journal-title":"Heart."},{"issue":"20","key":"B8-20261103","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation."},{"issue":"9","key":"B9-20261103","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1681\/ASN.2016010027","article-title":"Social determinants of racial disparities in CKD","volume":"27","author":"Norton","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"5","key":"B10-20261103","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCRESAHA.121.319811","article-title":"Social determinants of cardiovascular disease","volume":"130","author":"Powell-Wiley","year":"2022","journal-title":"Circ Res."},{"issue":"13","key":"B11-20261103","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med."},{"issue":"11","key":"B12-20261103","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","article-title":"Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association","volume":"119","author":"Zoccali","year":"2023","journal-title":"Cardiovasc Res."},{"issue":"23","key":"B13-20261103","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/eurheartj\/ehaf167","article-title":"Cardiovascular disease in chronic kidney disease","volume":"46","author":"Marx-Sch\u00fctt","year":"2025","journal-title":"Eur Heart J."},{"issue":"2","key":"B14-20261103","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1681\/ASN.2006060573","article-title":"Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency","volume":"18","author":"London","year":"2007","journal-title":"J Am Soc Nephrol."},{"issue":"20","key":"B15-20261103","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med."},{"issue":"11","key":"B16-20261103","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest."},{"issue":"19","key":"B17-20261103","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Guti\u00e9rrez","year":"2009","journal-title":"Circulation."},{"issue":"5","key":"B18-20261103","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ki.2013.332","article-title":"Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency","volume":"85","author":"Jimbo","year":"2014","journal-title":"Kidney Int."},{"issue":"22","key":"B19-20261103","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.jacc.2025.08.015","article-title":"Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023","volume":"86","year":"2025","journal-title":"J Am Coll Cardiol."},{"issue":"17","key":"B20-20261103","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc Res."},{"issue":"11","key":"B21-20261103","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/ejhf.3710","article-title":"Insights into the European heart failure epidemiology","volume":"27","author":"Seferovi\u0107","year":"2025","journal-title":"Eur J Heart Fail."},{"issue":"4","key":"B22-20261103","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jacasi.2024.01.013","article-title":"Epidemiology and burden of heart failure in Asia","volume":"4","author":"Feng","year":"2024","journal-title":"JACC Asia."},{"issue":"16","key":"B23-20261103","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation."},{"issue":"6","key":"B24-20261103","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.kint.2019.02.022","article-title":"Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"95","author":"House","year":"2019","journal-title":"Kidney Int."},{"issue":"4","key":"B25-20261103","doi-asserted-by":"crossref","first-page":"102943","DOI":"10.1016\/j.jchf.2026.102943","article-title":"Kidney disease and heart failure: recent advances and current challenges: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference","volume":"14","author":"Lam","year":"2026","journal-title":"JACC Heart Fail."},{"issue":"12","key":"B26-20261103","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/ki.2009.477","article-title":"Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy","volume":"77","author":"Wizemann","year":"2010","journal-title":"Kidney Int."},{"issue":"3","key":"B27-20261103","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2020030301","article-title":"Two-week burden of arrhythmias across CKD severity in a large community-based cohort: the ARIC study","volume":"32","author":"Kim","year":"2021","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B28-20261103","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/ndt\/gfv009","article-title":"Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis","volume":"30","author":"Masson","year":"2015","journal-title":"Nephrol Dial Transplant."},{"issue":"8","key":"B29-20261103","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S1474-4422(14)70026-2","article-title":"Stroke and cerebrovascular diseases in patients with chronic kidney disease","volume":"13","author":"Toyoda","year":"2014","journal-title":"Lancet Neurol."},{"issue":"9889","key":"B30-20261103","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet."},{"issue":"5","key":"B31-20261103","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention","volume":"42","author":"Sarnak","year":"2003","journal-title":"Hypertension."},{"issue":"2","key":"B32-20261103","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2215\/CJN.03670807","article-title":"Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?","volume":"3","author":"Stenvinkel","year":"2008","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"B33-20261103","doi-asserted-by":"crossref","first-page":"2472039","DOI":"10.1080\/0886022X.2025.2472039","article-title":"Global, regional, and national burden of cardiovascular disease attributable to kidney dysfunction (1990-2021) with projections to 2050: analysis of the 2021 global burden of disease study","volume":"47","author":"Zhang","year":"2025","journal-title":"Ren Fail."},{"issue":"8","key":"B34-20261103","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2215\/CJN.00070109","article-title":"Chronic Renal Insufficiency Cohort (CRIC) study: baseline characteristics and associations with kidney function","volume":"4","author":"Lash","year":"2009","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"B35-20261103","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1053\/j.ajkd.2016.03.429","article-title":"Race\/ethnicity and cardiovascular outcomes in adults with CKD: findings from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC studies","volume":"68","author":"Lash","year":"2016","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"B36-20261103","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1053\/j.ajkd.2019.08.011","article-title":"Race and mortality in CKD and dialysis: findings from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"75","author":"Ku","year":"2020","journal-title":"Am J Kidney Dis."},{"issue":"5","key":"B37-20261103","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000368915","article-title":"Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC study","volume":"40","author":"Rahman","year":"2014","journal-title":"Am J Nephrol."},{"issue":"6","key":"B38-20261103","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1159\/000327618","article-title":"Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: findings from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"33","author":"Townsend","year":"2011","journal-title":"Am J Nephrol."},{"issue":"5","key":"B39-20261103","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1053\/j.ajkd.2010.05.016","article-title":"Relationship between body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort","volume":"56","author":"Toto","year":"2010","journal-title":"Am J Kidney Dis."},{"issue":"9","key":"B40-20261103","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.2215\/CJN.11341210","article-title":"Cardiovascular disease among hispanics and non-hispanics in the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"6","author":"Ricardo","year":"2011","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B41-20261103","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1053\/j.ajkd.2011.05.010","article-title":"CKD in Hispanics: baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC studies","volume":"58","author":"Fischer","year":"2011","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B42-20261103","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.ajkd.2023.12.014","article-title":"APOL1 nephropathy risk variants through the life course: a review","volume":"84","author":"Itoku","year":"2024","journal-title":"Am J Kidney Dis."},{"issue":"9","key":"B43-20261103","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans","volume":"24","author":"Foster","year":"2013","journal-title":"J Am Soc Nephrol."},{"issue":"23","key":"B44-20261103","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1056\/NEJMoa1310345","article-title":"APOL1 risk variants, race, and progression of chronic kidney disease","volume":"369","author":"Parsa","year":"2013","journal-title":"N Engl J Med."},{"issue":"9","key":"B45-20261103","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/ATVBAHA.117.309384","article-title":"APOL1 risk variants and cardiovascular disease: results from the AASK (African American Study of Kidney Disease and Hypertension)","volume":"37","author":"Chen","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"9","key":"B46-20261103","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1161\/ATVBAHA.117.309756","article-title":"APOL1 and cardiovascular disease: a story in evolution","volume":"37","author":"Bajaj","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"7","key":"B47-20261103","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1681\/ASN.2007070747","article-title":"Racial differences in mortality among those with CKD","volume":"19","author":"Mehrotra","year":"2008","journal-title":"J Am Soc Nephrol."},{"issue":"18","key":"B48-20261103","doi-asserted-by":"crossref","first-page":"e026998","DOI":"10.1161\/JAHA.122.026998","article-title":"Race, biomarkers, and cardiovascular disease in patients with chronic kidney disease","volume":"11","author":"Nicholas","year":"2022","journal-title":"J Am Heart Assoc."},{"issue":"3","key":"B49-20261103","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ndt\/gfu294","article-title":"Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort","volume":"30","author":"Titze","year":"2015","journal-title":"Nephrol Dial Transplant."},{"issue":"6","key":"B50-20261103","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1053\/j.ajkd.2010.06.010","article-title":"Factors associated with kidney disease progression and mortality in a referred CKD population","volume":"56","author":"Hoefield","year":"2010","journal-title":"Am J Kidney Dis."},{"issue":"suppl 3","key":"B51-20261103","doi-asserted-by":"crossref","first-page":"iii27","DOI":"10.1093\/ndt\/gfs277","article-title":"The EQUAL study: a European study in chronic kidney disease stage 4 patients","volume":"27","author":"Jager","year":"2012","journal-title":"Nephrol Dial Transplant."},{"issue":"9","key":"B52-20261103","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/ndt\/gfaa095","article-title":"Renal function decline in older men and women with advanced chronic kidney disease-results from the EQUAL study","volume":"36","author":"Chesnaye","year":"2021","journal-title":"Nephrol Dial Transplant."},{"issue":"2","key":"B53-20261103","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1053\/j.ajkd.2021.05.018","article-title":"A predictive model for progression of CKD to kidney failure based on routine laboratory tests","volume":"79","author":"Zacharias","year":"2022","journal-title":"Am J Kidney Dis."},{"issue":"4","key":"B54-20261103","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1053\/j.ajkd.2022.01.424","article-title":"Heart-type fatty acid binding protein, cardiovascular outcomes, and death: findings from the German CKD cohort study","volume":"80","author":"Schneider","year":"2022","journal-title":"Am J Kidney Dis."},{"issue":"11","key":"B55-20261103","doi-asserted-by":"crossref","first-page":"100725","DOI":"10.1016\/j.xkme.2023.100725","article-title":"Copeptin, natriuretic peptides, and cardiovascular outcomes in patients with CKD: the German Chronic Kidney Disease (GCKD) study","volume":"5","author":"Schneider","year":"2023","journal-title":"Kidney Med."},{"issue":"10","key":"B56-20261103","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1016\/j.ekir.2022.07.165","article-title":"Predicting kidney failure, cardiovascular disease and death in advanced CKD patients","volume":"7","author":"Ramspek","year":"2022","journal-title":"Kidney Int Rep."},{"issue":"3","key":"B57-20261103","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s10157-016-1309-1","article-title":"Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study","volume":"21","author":"Inaguma","year":"2017","journal-title":"Clin Exp Nephrol."},{"issue":"2","key":"B58-20261103","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3346\/jkms.2017.32.2.221","article-title":"Baseline general characteristics of the Korean chronic kidney disease: report from the KoreaN Cohort Study for Outcomes in Patients with Chronic Kidney Disease (KNOW-CKD)","volume":"32","author":"Kang","year":"2017","journal-title":"J Korean Med Sci."},{"issue":"1","key":"B59-20261103","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12882-017-0441-9","article-title":"Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE)","volume":"18","author":"Yuan","year":"2017","journal-title":"BMC Nephrol."},{"issue":"2","key":"B60-20261103","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2215\/CJN.0000000884","article-title":"Ethnic disparities in chronic kidney disease progression: a comparative study of CRIC and KNOW-CKD cohorts","volume":"21","author":"Ko","year":"2026","journal-title":"Clin J Am Soc Nephrol."},{"issue":"21","key":"B61-20261103","doi-asserted-by":"crossref","first-page":"e017980","DOI":"10.1161\/JAHA.120.017980","article-title":"Low high-sensitivity C-reactive protein level in Korean patients with chronic kidney disease and its predictive significance for cardiovascular events, mortality, and adverse kidney outcomes: results from KNOW-CKD","volume":"9","author":"Lee","year":"2020","journal-title":"J Am Heart Assoc."},{"issue":"8","key":"B62-20261103","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1681\/ASN.2022010080","article-title":"Coronary artery calcification score and the progression of chronic kidney disease","volume":"33","author":"Yun","year":"2022","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B63-20261103","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/jamacardio.2017.0363","article-title":"Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease","volume":"2","author":"Chen","year":"2017","journal-title":"JAMA Cardiol."},{"issue":"5","key":"B64-20261103","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.kint.2023.01.008","article-title":"Excess risk of cardiovascular events in patients in the United States vs. Japan with chronic kidney disease is mediated mainly by left ventricular structure and function","volume":"103","author":"Imaizumi","year":"2023","journal-title":"Kidney Int."},{"issue":"18","key":"B65-20261103","doi-asserted-by":"crossref","first-page":"e013357","DOI":"10.1161\/JAHA.119.013357","article-title":"Association between high-sensitivity cardiac troponin T and echocardiographic parameters in chronic kidney disease: results from the KNOW-CKD cohort study","volume":"8","author":"Kang","year":"2019","journal-title":"J Am Heart Assoc."},{"issue":"1","key":"B66-20261103","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1159\/000519190","article-title":"Longitudinal follow-up and outcomes for Chinese patients with stage 1\u20134 chronic kidney disease","volume":"8","author":"Wang","year":"2022","journal-title":"Kidney Dis."},{"issue":"1","key":"B67-20261103","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41598-020-80877-y","article-title":"Incidence of cardiovascular events and mortality in Korean patients with chronic kidney disease","volume":"11","author":"Ryu","year":"2021","journal-title":"Sci Rep."},{"issue":"1","key":"B68-20261103","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/ckj\/sfab149","article-title":"The Indian Chronic Kidney Disease (ICKD) study: baseline characteristics","volume":"15","author":"Kumar","year":"2022","journal-title":"Clin Kidney J."},{"issue":"6","key":"B69-20261103","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1159\/000503873","article-title":"Impact of kidney function on cardiovascular risk and mortality: a comparison of South Asian and European cohorts","volume":"50","author":"Eastwood","year":"2019","journal-title":"Am J Nephrol."},{"issue":"12","key":"B70-20261103","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2215\/CJN.11951214","article-title":"Human heredity and health (H3) in Africa kidney disease research network: a focus on methods in Sub-Saharan Africa","volume":"10","author":"Osafo","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"B71-20261103","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/CIRCRESAHA.123.324001","article-title":"Cardiovascular consequences of uremic metabolites: an overview of the involved signaling pathways","volume":"134","author":"Curaj","year":"2024","journal-title":"Circ Res."},{"issue":"12","key":"B72-20261103","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1681\/ASN.V12122747","article-title":"Oxidative stress and endothelial function in chronic renal failure","volume":"12","author":"Annuk","year":"2001","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B73-20261103","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12933-023-01937-x","article-title":"The cardio-renal-metabolic connection: a review of the evidence","volume":"22","author":"Marassi","year":"2023","journal-title":"Cardiovasc Diabetol."},{"issue":"1","key":"B74-20261103","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1752-8062.2011.00264.x","article-title":"Racial differences in oxidative stress and inflammation: in vitro and in vivo","volume":"4","author":"Feairheller","year":"2011","journal-title":"Clin Transl Sci."},{"issue":"3","key":"B75-20261103","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1053\/j.ajkd.2020.05.031","article-title":"Associations of serum calciprotein particle size and transformation time with arterial calcification, arterial stiffness, and mortality in incident hemodialysis patients","volume":"77","author":"Chen","year":"2021","journal-title":"Am J Kidney Dis."},{"issue":"5","key":"B76-20261103","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/ndt\/gfz190","article-title":"Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification","volume":"35","author":"Ter Braake","year":"2020","journal-title":"Nephrol Dial Transplant."},{"issue":"6","key":"B77-20261103","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1053\/j.ajkd.2019.01.024","article-title":"Serum calcification propensity and coronary artery calcification among patients with CKD: the CRIC (Chronic Renal Insufficiency Cohort) study","volume":"73","author":"Bundy","year":"2019","journal-title":"Am J Kidney Dis."},{"issue":"9822","key":"B78-20261103","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(11)61931-4","article-title":"Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies","volume":"379","author":"Sarwar","year":"2012","journal-title":"Lancet."},{"issue":"7","key":"B79-20261103","doi-asserted-by":"crossref","first-page":"100249","DOI":"10.1016\/j.advnut.2024.100249","article-title":"Dietary patterns and cardiovascular diseases in Asia: a systematic review and meta-analysis","volume":"15","author":"Lim","year":"2024","journal-title":"Adv Nutr."},{"issue":"3","key":"B80-20261103","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/jch.14188","article-title":"Hypertension and chronic kidney disease in Asian populations","volume":"23","author":"Teo","year":"2021","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"5","key":"B81-20261103","doi-asserted-by":"crossref","first-page":"F729","DOI":"10.1152\/ajprenal.00407.2020","article-title":"Salt-sensitive hypertension in chronic kidney disease: distal tubular mechanisms","volume":"319","author":"Bov\u00e9e","year":"2020","journal-title":"Am J Physiol Renal Physiol."},{"issue":"1","key":"B82-20261103","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/diagnostics15010021","article-title":"The gut-kidney axis in chronic kidney diseases","volume":"15","author":"Tsuji","year":"2024","journal-title":"Diagnostics (Basel)."},{"issue":"1","key":"B83-20261103","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3390\/biomedicines14010109","article-title":"Gut-kidney axis: unraveling the role of the microbiome in chronic kidney disease","volume":"14","author":"Rusu","year":"2026","journal-title":"Biomedicines."},{"key":"B84-20261103","doi-asserted-by":"crossref","first-page":"1620247","DOI":"10.3389\/fmed.2025.1620247","article-title":"Gut microbiome remodeling in chronic kidney disease: implications of kidney replacement therapies and therapeutic interventions","volume":"12","author":"Wang","year":"2025","journal-title":"Front Med (Lausanne)."},{"issue":"18","key":"B85-20261103","doi-asserted-by":"crossref","first-page":"e025627","DOI":"10.1161\/JAHA.122.025627","article-title":"Race, interleukin-6, TMPRSS6 genotype, and cardiovascular disease in patients with chronic kidney disease","volume":"11","author":"Barrows","year":"2022","journal-title":"J Am Heart Assoc."},{"issue":"12","key":"B86-20261103","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1681\/ASN.2011030305","article-title":"Inflammation and the paradox of racial differences in dialysis survival","volume":"22","author":"Crews","year":"2011","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"B87-20261103","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2337\/db24-0483","article-title":"Blood-based epigenetic biomarkers associated with incident chronic kidney disease in individuals with type 2 diabetes","volume":"74","author":"Marchiori","year":"2025","journal-title":"Diabetes."},{"issue":"1","key":"B88-20261103","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000549108","article-title":"Global burden of cardiovascular disease attributable to kidney dysfunction, 1990-2021: a comprehensive analysis of trends and forecasts to 2050","volume":"57","author":"Huang","year":"2026","journal-title":"Am J Nephrol."},{"issue":"1","key":"B89-20261103","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41746-021-00428-1","article-title":"Medical records-based chronic kidney disease phenotype for clinical care and \u201cbig data\u201d observational and genetic studies","volume":"4","author":"Shang","year":"2021","journal-title":"NPJ Digit Med."},{"issue":"2","key":"B90-20261103","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2215\/CJN.0000000984","article-title":"Beyond the data: an Asian patient's perspective on the \u201cAsian Paradox\u201d in Kkdney Ddsease","volume":"21","author":"Wang","year":"2026","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"B91-20261103","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1053\/j.ajkd.2006.08.004","article-title":"Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) trial","volume":"48","author":"Norris","year":"2006","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"B92-20261103","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/ndt\/gfad195","article-title":"Proteinuria, measured or estimated albuminuria for risk prediction in patients with chronic kidney disease?","volume":"39","author":"Kim","year":"2024","journal-title":"Nephrol Dial Transplant."},{"issue":"10","key":"B93-20261103","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa0910975","article-title":"Intensive blood-pressure control in hypertensive chronic kidney disease","volume":"363","author":"Appel","year":"2010","journal-title":"N Engl J Med."},{"issue":"1","key":"B94-20261103","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.kint.2016.09.015","article-title":"Cardiovascular events and death in Japanese patients with chronic kidney disease","volume":"91","author":"Tanaka","year":"2017","journal-title":"Kidney Int."},{"issue":"5","key":"B95-20261103","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10157-018-01684-4","article-title":"Optimal follow-up intervals for different stages of chronic kidney disease: a prospective observational study","volume":"23","author":"Hirano","year":"2019","journal-title":"Clin Exp Nephrol."},{"issue":"3","key":"B96-20261103","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/ndt\/gfac194","article-title":"Association of coronary artery calcium with adverse cardiovascular outcomes and death in patients with chronic kidney disease: results from the KNOW-CKD","volume":"38","author":"Jung","year":"2023","journal-title":"Nephrol Dial Transplant."},{"issue":"4","key":"B97-20261103","doi-asserted-by":"crossref","first-page":"e0122552","DOI":"10.1371\/journal.pone.0122552","article-title":"Heart failure in a cohort of patients with chronic kidney disease: the GCKD study","volume":"10","author":"Beck","year":"2015","journal-title":"PLoS One."},{"issue":"2","key":"B98-20261103","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ekir.2018.10.004","article-title":"Left ventricular structure in patients with mild-to-moderate CKD-a magnetic resonance imaging study","volume":"4","author":"Schneider","year":"2019","journal-title":"Kidney Int Rep."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000001156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:00:53Z","timestamp":1793728853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000001156"}},"subtitle":["Ethnic and Regional Differences in Risk and Phenotype"],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":98,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000001156","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}